Physician profile
April Horner
NPI 1649638651
$510.95
in general payments reported to CMS, 2019-2025
15 companies · $193 in 2025
The $193 reported for 2025 was more than what 80% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $33.84 · 2023: $125 · 2024: $31.15 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $70.35 | 2025 | Endosee |
| Hologic Sales and Service, LLC | $54.50 | 2021-2024 | Coolseal Generator, Acessa Provu System |
| Therapeuticsmd, INC. | $49.07 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.30 | 2023-2024 | |
| Novo Nordisk INC | $39.28 | 2023 | |
| Myovant Sciences INC. | $37.44 | 2021 | |
| Mayne Pharma Commercial LLC | $36.84 | 2023-2025 | |
| Biogen, INC. | $28.28 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $26.95 | 2025 | Myfembree |
| Otsuka America Pharmaceutical, INC. | $25.55 | 2025 | Rexulti |
| Agile Therapeutics, INC. | $24.10 | 2021 | |
| Dexcom, INC. | $22.27 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $19.31 | 2023 | |
| Evofem Biosciences, INC. | $15.87 | 2021 | |
| Daiichi Sankyo INC. | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Horner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.